LivaNova Posts $393.1M in Third-Quarter Revenue
LIVN sits 64% above its 52-week low of $48.82.
Summary
LivaNova reported third-quarter revenue of $393.1M, up modestly from the $390.6M it posted in Q2, and adjusted EPS of $1.23. The sequential gain is small, so the top line alone doesn't tell us much about the quarter's quality. Q2 came in at +10.8% growth with a guidance raise, so the bar was set high; whether this figure clears consensus isn't stated in the headline. The company raised its 2026 view to adjusted EPS of $4.40 to $4.50.
At the time of this announcement, LIVN was trading at $79.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $48.82 to $85.76. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.